Zambon
Nicoletta Cagnato is an experienced professional in pharmacovigilance and safety evaluation, currently serving as the Safety Evaluation & Risk Management Lead at Zambon since June 2024. Prior to this role, Nicoletta was the Deputy Qualified Person for Pharmacovigilance at DOC GENERICI from May 2016 to May 2024, where responsibilities included serving as a back-up for the EU-QPPV and managing pharmacovigilance activities. Earlier positions include Pharmacovigilance Specialist at OPIS, Pharmacovigilance Officer at GlaxoSmithKline Consumer Healthcare, and Drug Safety Officer at GB Pharma Group. Nicoletta's educational background includes a second-level master's degree in pharmacovigilance and a Master’s degree in pharmaceutical and chemistry technology from prestigious Italian universities.
This person is not in any teams
This person is not in any offices
Zambon
7 followers
Zambon is a multinational pharmaceutical and chemical company that focuses on innovation and development with the aim to improve the quality of people’s health and patients’ lives. Based on a valuable heritage but strongly focused on the future, its Vision is “Innovating cure and care to make patients’ lives better”.